Venlafaxine in Preventing Chronic Oxaliplatin-Induced Neuropathy In Patients Receiving Combination Chemotherapy

NCT01611155 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Neuropathy

Interventions

DRUG: venlafaxine
DRUG: placebo
OTHER: questionnaire administration
OTHER: quality-of-life assessment

Sponsor

Mayo Clinic